Condition

Trichomonas Vaginitis

ClinicalTrials.gov condition label

Clinical trials7

Recruiting0

Common interventions4

Lead sponsors shown5

Clinical trials

7 shown

Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South AfricaNCT06131749 · 2021-03-01

MAMAS: Mentoring Adolescent Mothers at SchoolNCT03090802 · 2017-06-26

DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative WomenNCT01874158 · 2012-11-01

Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in MalawiNCT00140764 · 2003-01-01

Safety and Acceptability of Carraguard™ Among HIV-negative Couples in ThailandNCT00213057 · 2001-06-01

Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideNCT00213031 · 2000-02-01

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI TransmissionNCT00213018 · 1999-10-01

Common interventions

Carraguard (PC-515)DRUG3 Mentoring Adolescent Mothers at School (MAMAS)BEHAVIORAL1 Metronidazole gel versus placebo gelDRUG1 No interventionOTHER1

Leading sponsors

Population Council3 Drexel University1 Johns Hopkins Bloomberg School of Public Health1 Tulane University Health Sciences Center1 University of Bern1

Trial status mix

COMPLETED7

Phase mix

PHASE22

NA1

PHASE11

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.